Advances in pharmacologic therapies for type 2 diabetes.
about
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).The importance of synthetic drugs for type 2 diabetes drug discovery.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic β-cells via AMPK activation.Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety
P2860
Advances in pharmacologic therapies for type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in pharmacologic therapies for type 2 diabetes.
@en
type
label
Advances in pharmacologic therapies for type 2 diabetes.
@en
prefLabel
Advances in pharmacologic therapies for type 2 diabetes.
@en
P2860
P1476
Advances in pharmacologic therapies for type 2 diabetes.
@en
P2093
Linde M Morsink
Michaela Diamant
P2860
P2888
P356
10.1007/S11883-012-0302-8
P50
P577
2013-02-01T00:00:00Z
P6179
1036092257